Vascular calcification: in vitro evidence for the role of inorganic phosphate.
about
Calciphylaxis--a topical overviewCharacterization of transport mechanisms and determinants critical for Na+-dependent Pi symport of the PiT family paralogs human PiT1 and PiT2Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pigNFκB-sensitive Orai1 expression in the regulation of FGF23 release.Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone diseaseIntakes of Calcium and Phosphorus and Calculated Calcium-to-Phosphorus Ratios of Older Adults: NHANES 2005-2006 Data.Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul StudyChronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.Atherogenesis and iron: from epidemiology to cellular level.The emerging role of phosphate in vascular calcification.Vascular Calcification: Current Genetics Underlying This Complex Phenomenon.Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients.Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing ReceptorLifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesisComparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patientsSerum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).Is coronary artery calcification associated with vertebral bone density in nondialyzed chronic kidney disease patients?Common genetic variants associate with serum phosphorus concentration.Klotho and kidney disease.Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cellsCardiovascular risk factors in chronic kidney disease: does phosphate qualify?Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.Idiopathic Recurrent Calcium Urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma--a comparison of stone-free and -bearing male patients, emphasSerum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal DysfunctionNH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.The demise of calcium-based phosphate binders-is this appropriate for children?Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPSMicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification.Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure.Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector.Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification.An integrated understanding of the physiological response to elevated extracellular phosphate.Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysisDietary phosphorus acutely impairs endothelial function.Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells.Similarities and differences in coatings for magnesium-based stents and orthopaedic implants.Phosphate-induced rat vascular smooth muscle cell calcification and the implication of zinc deficiency in a7r5 cell viability.
P2860
Q28239109-1D9841BA-BDEE-4C3A-9581-46DD168177E0Q28247544-B73174E7-1124-4759-A69A-79FAC1B95344Q28383746-BDFDF6F1-B163-463B-B041-AE63760D4967Q30315916-7BAFE367-36CF-4BC6-9466-857CB31A0A59Q30852321-6D716E21-CFF7-41D9-871A-713829D5247CQ31028489-E41B82EB-5D2C-4FCE-92D3-F27EC1CF2F41Q31111874-184647A6-928E-477C-A757-D50422E8F2D2Q33562186-EC3E9369-BA2A-4F3D-A9DA-7C66263435B5Q33595279-E8EBA04A-6934-4A24-ABCE-F0B66B438F2AQ33595584-AF107C3D-FD5C-483F-BC60-FC792558A5C5Q33646711-505C75BD-F66B-4DD5-97A1-9C187058FBEAQ33700483-A5A48410-E1E9-487A-92E0-2115A3030298Q33873467-36654F42-F045-4941-8272-5EC63FA9EEF6Q33918759-B09A1A35-CBAA-4643-BD0D-82238AFF19D9Q34187537-18965A8A-8786-4F89-81B0-5EA301EDF365Q34497220-38821233-8A85-456A-88F4-C8035DFED57BQ34611536-1ED0A644-56D0-47DB-B02A-F887CD4D05E5Q35030657-5DDC0B94-05FF-49EB-BC41-F6DF94C2DAC2Q35153194-B68D98B7-52A3-42CD-92FE-B80507D3EAFDQ35582566-00B8604B-AA0A-42E7-925C-F024E0E1B4A1Q35669331-DB53CBDD-02F5-4AA3-88C8-EE2C1581CC7BQ35679887-6FA05E35-A748-4AC4-8EEB-899270C7D29AQ35695757-F10DD35E-135E-431F-BE11-6CC3FDA04EF5Q35959137-63E74F09-E377-4FB8-89AE-1D751DA2618FQ35963073-BE660C19-1D2F-4DEB-9FA4-A5851151C532Q36104780-CF272764-1890-4915-A7DE-F53659951BE7Q36214854-D9883001-2005-4711-95F9-58C171193CD8Q36279054-4B1F6D59-6AEF-4B54-8C20-FA5AA8026575Q36314694-EC47E554-69AF-490F-88F9-596CD1E4DD7EQ36349354-99BF3245-5D30-456B-A8BC-D57DFC3906E9Q36504284-9D37FCC7-D528-4CD2-84E6-308F7D257B1BQ36538166-898EC7A6-68A3-434F-B0B0-27738AF6B7CCQ36580372-9522D563-8F20-454B-98F2-2E2F25D8098BQ36684209-AE4A956C-3BAE-482C-9725-16C847950787Q36986316-592E65B1-8F60-458B-ADB3-ACC2548FDA8CQ37052751-2C26B469-F6BB-426C-84E6-F09B33FA59B4Q37259290-C5432C38-66F2-4498-83D1-292C57AF85D0Q37294947-EFD341C7-3157-461F-9BDC-B8579BEFB197Q37300521-C81BBD2F-460A-4019-84F7-F9A8038778DAQ37481549-32773EF8-4284-4A42-8BA7-79C09D35E367
P2860
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@ast
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@en
type
label
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@ast
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@en
prefLabel
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@ast
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@en
P1476
Vascular calcification: in vitro evidence for the role of inorganic phosphate.
@en
P2093
Cecilia M Giachelli
P304
P356
10.1097/01.ASN.0000081663.52165.66
P433
P577
2003-09-01T00:00:00Z